Re: Chemotherapy-related myelosuppression as a marker for survival in epithelial ovarian cancer patients by Rocconi et al.

被引：1
|
作者：
Petru, Edgar [1 ]
机构：
[1] Med Univ Graz, Dept Obstet & Gynecol, A-8036 Graz, Austria
来源：
GYNECOLOGIC ONCOLOGY | 2008年 / 111卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2008.06.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：159 / 160
页数：2
相关论文
共 50 条
  • [31] RURAL RESIDENCE IS RELATED TO POORER QUALITY OF LIFE AND SHORTER SURVIVAL IN EPITHELIAL OVARIAN CANCER PATIENTS
    Lutgendorf, Susan K.
    Kinner, Ellen M.
    Schrepf, Andrew
    Ramirez, Edgardo
    Thaker, Premal H.
    Goodheart, Michael J.
    Bender, David P.
    Strack, Sarah K.
    Noble, Alyssa K.
    Slavich, George M.
    Sood, Anil K.
    Cole, Steve W.
    PSYCHOSOMATIC MEDICINE, 2019, 81 (04): : A115 - A115
  • [32] Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
    Rutten, Iris J. G.
    van Dijk, David P. J.
    Kruitwagen, Roy F. P. M.
    Beets-Tan, Regina G. H.
    Damink, Steven W. M. Olde
    van Gorp, Toon
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2016, 7 (04) : 458 - 466
  • [33] Authors' reply - Re: Wang et al. Controversial role of the possible oxyntic stem cell marker ASPM in gastric cancer
    Vange, Pal
    Bruland, Torunn
    Bakke, Ingunn
    JOURNAL OF PATHOLOGY, 2017, 241 (04): : 562 - 563
  • [34] Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer center
    Board, RE
    Bruijns, CTPH
    Pronk, AE
    Ryder, WDJ
    Wilkinson, PM
    Welch, R
    Shanks, JH
    Connolly, G
    Slade, RJ
    Reynolds, K
    Kitchener, HC
    Jayson, GC
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 : 18 - 24
  • [35] Commentary on kaneko et al.:: Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification
    Brodeur, GM
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (08) : 608 - 609
  • [36] Factors related to recurrence after pathological complete response to postoperative chemotherapy in patients with epithelial ovarian cancer
    Karagol, Hakan
    Saip, Pinar
    Eralp, Yesim
    Topuz, Samet
    Berkman, Sinan
    Ilhan, Ridvan
    Topuz, Erkan
    TUMORI, 2009, 95 (02) : 207 - 211
  • [37] Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer
    Spizzo, Gilbert
    Went, Philip
    Dirnhofer, Stephan
    Obrist, Peter
    Moch, Holger
    Baeuerle, Patrick A.
    Mueller-Holzner, Elisabeth
    Marth, Christian
    Gastl, Guenther
    Zeimet, Alain G.
    GYNECOLOGIC ONCOLOGY, 2006, 103 (02) : 483 - 488
  • [38] Re: Earle et al., Effect of Lymph Node Retrieval Rates on Utilization of Adjuvant Chemotherapy in Stage II Colon Cancer
    Simunovic, Marko
    Baxter, Nancy
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (07) : 645 - 645
  • [39] Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer
    Tanaka, N
    Matsui, H
    Nagai, Y
    Suzuka, K
    Seki, K
    Sekiya, S
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2002, 23 (04) : 281 - 286
  • [40] Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy
    Staley, S. Allison
    Tucker, Katherine
    Newton, Meredith
    Ertel, Michelle
    Oldan, Jorge
    Doherty, Irene
    West, Lindsay
    Zhang, Yingao
    Gehrig, Paola A.
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 695 - 700
12345